ENTA: Enanta Pharmaceuticals, Inc Company Profile & Statistics

Enanta Pharmaceuticals, Inc Profile

About

Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.

Info & Links

CEO

Jay R. Luly

Headquarters

4 KINGSBURY AVENUE
WATERTOWN, MA 02472, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

120

Enanta Pharmaceuticals, Inc Statistics

Valuation Measures

Market Capitalization²

408.98M

Enterprise Value

376.69M

Enterprise Value/EBITDA(ttm)

-4.69

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

6.56

Price to Book(mrq)

4.91

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-125.36%

Profit Margin(ttm)

-126.61%

Return on Equity(ttm)

-93.76%

Return on Invested Capital(ttm)

-96.06%

Return on Assets(ttm)

-26.13%

Income Statement

Revenue(ttm)

65.32M

Revenue Per Share(ttm)

2.26

Gross Profit(ttm)

65.32M

EBITDA(ttm)³

-80.26M

Net Income Available to Common(ttm)

-81.89M

Diluted EPS(ttm)

-3.83

Share Statistics

Beta (5Y Monthly)

0.96

52-Week Change

132.46%

S&P 500 52-Week Change

14.46%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

28.86M

Dividend Yield

0.00%

Float⁴

24.85M

% Held by Insiders

13.89%

% Held by Institutions

94.99%

Balance Sheet

Total Cash(mrq)

188.86M

Total Cash Per Share(mrq)

6.54

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.21%

Quick Ratio(mrq)

4.21%

Book Value Per Share(mrq)

3.03

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.90

Free Cash Flow(ytd)

-32.17M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ENTA

Enanta Pharmaceuticals, Inc